Provided by Tiger Trade Technology Pte. Ltd.

TELA Bio, Inc.

1.25
-0.0400-3.10%
Post-market: 1.290.0400+3.20%19:30 EDT
Volume:481.12K
Turnover:601.26K
Market Cap:56.43M
PE:-1.61
High:1.33
Open:1.31
Low:1.17
Close:1.29
52wk High:1.69
52wk Low:0.5011
Shares:45.14M
Float Shares:21.74M
Volume Ratio:1.34
T/O Rate:2.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7776
EPS(LYR):-0.8300
ROE:-616.62%
ROA:-33.40%
PB:-3.56
PE(LYR):-1.51

Loading ...

TELA Bio Shareholders Expand Equity Incentive Plan Authorization

TIPRANKS
·
Jun 12

TELA Bio shareholders approve 3.5 million-share increase to equity incentive plan

Reuters
·
Jun 12

Lake Street Keeps Their Buy Rating on TELA Bio (TELA)

TIPRANKS
·
May 13

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA)

TIPRANKS
·
May 13

TELA Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

TELA Bio posts modest Q1 growth, maintains 2026 outlook

TIPRANKS
·
May 13

TELA Bio Q1 net loss widens to $12.3 million; revenue rises 3% to $19.1 million

Reuters
·
May 13

TELA Bio Q1 EPS $(0.21) Misses $(0.18) Estimate, Sales $19.059M Beat $18.597M Estimate

Benzinga Earnings
·
May 13

BRIEF-TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million

Reuters
·
May 13

TELA Bio Q1 Income From Operations USD -10.526 Million

THOMSON REUTERS
·
May 13

TELA Bio Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 13

TELA Bio Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
May 09

TELA Bio grants 89,250 restricted stock units to 12 new hires

Reuters
·
May 08

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 08

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Irhythm Technologies (IRTC) and TELA Bio (TELA)

TIPRANKS
·
May 01

TELA Bio Reshapes Board, Appoints New Chairman, Directors

TIPRANKS
·
May 01

TELA Bio sees Q1 revenue about $19 million, above prior $18.5 million view

Reuters
·
May 01

TELA Bio names Joseph Capper board chair in four-director refreshment plan

Reuters
·
May 01

TELA Bio Inc - Prelim Q1 2026 Revenue Approx $19.0 Mln Versus Guidance of $18.5 Mln

THOMSON REUTERS
·
May 01

TELA Bio Inc - Joseph Capper to Be Nominated as Director and Expected to Serve as Chair

THOMSON REUTERS
·
May 01